Credit Suisse Ag Crispr Therapeutics Ag Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Credit Suisse Ag holds 719,309 shares of CRSP stock, worth $29.3 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

719,309

Previous 876,145 17.9%

Holding current value

$29.3 Million

Previous $54.8 Million 10.61%

% of portfolio

0.05%

Previous 0.05%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$60.67 - $89.12 $9.52 Million - $14 Million	-156,836 Reduced 17.9%	719,309 $49 Million
Q4 2023 Feb 08, 2024	BUY	$38.62 - $72.18 $124,124 - $231,986	3,214 Added 0.37%	876,145 $54.8 Million
Q3 2023 Nov 13, 2023	SELL	$45.39 - $59.0 $2.21 Million - $2.87 Million	-48,725 Reduced 5.29%	872,931 $39.6 Million
Q2 2023 Aug 11, 2023	BUY	$43.47 - $67.77 $3.23 Million - $5.04 Million	74,383 Added 8.78%	921,656 $51.7 Million
Q1 2023 May 10, 2023	SELL	$41.0 - $56.12 $230,256 - $315,169	-5,616 Reduced 0.66%	847,273 $38.3 Million
Q4 2022 Feb 13, 2023	BUY	$39.19 - $65.67 $477,451 - $800,057	12,183 Added 1.45%	852,889 $34.7 Million
Q3 2022 Nov 10, 2022	SELL	$61.1 - $83.78 $5.07 Million - $6.95 Million	-82,965 Reduced 8.98%	840,706 $54.9 Million
Q2 2022 Aug 12, 2022	SELL	$43.23 - $73.83 $4.07 Million - $6.95 Million	-94,156 Reduced 9.25%	923,671 $56.1 Million
Q1 2022 May 16, 2022	SELL	$53.19 - $79.24 $4.02 Million - $5.99 Million	-75,625 Reduced 6.92%	1,017,827 $63.9 Million
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $12.7 Million - $20.1 Million	180,911 Added 19.82%	1,093,452 $82.9 Million
Q3 2021 Nov 12, 2021	SELL	$110.2 - $156.64 $5.35 Million - $7.61 Million	-48,573 Reduced 5.05%	912,541 $102 Million
Q2 2021 Aug 16, 2021	BUY	$100.84 - $161.89 $4.28 Million - $6.86 Million	42,404 Added 4.62%	961,114 $156 Million
Q1 2021 May 14, 2021	BUY	$110.72 - $210.04 $13.9 Million - $26.3 Million	125,266 Added 15.79%	918,710 $112 Million
Q4 2020 Feb 12, 2021	BUY	$79.67 - $173.23 $7.26 Million - $15.8 Million	91,158 Added 12.98%	793,444 $121 Million
Q3 2020 Nov 13, 2020	SELL	$78.5 - $100.64 $1.85 Million - $2.38 Million	-23,624 Reduced 3.25%	702,286 $58.7 Million
Q2 2020 Aug 12, 2020	SELL	$38.5 - $76.05 $4.85 Million - $9.58 Million	-125,957 Reduced 14.79%	725,910 $53.3 Million
Q1 2020 May 13, 2020	BUY	$33.68 - $62.53 $4.4 Million - $8.16 Million	130,555 Added 18.1%	851,867 $36.1 Million
Q4 2019 Feb 12, 2020	SELL	$36.68 - $73.13 $312,366 - $622,775	-8,516 Reduced 1.17%	721,312 $43.9 Million
Q3 2019 Nov 12, 2019	SELL	$40.99 - $52.56 $2.81 Million - $3.61 Million	-68,644 Reduced 8.6%	729,828 $29.9 Million
Q2 2019 Aug 14, 2019	SELL	$35.45 - $48.2 $3.26 Million - $4.44 Million	-92,092 Reduced 10.34%	798,472 $37.6 Million
Q1 2019 May 14, 2019	BUY	$28.02 - $40.87 $3.24 Million - $4.73 Million	115,691 Added 14.93%	890,564 $31.8 Million
Q4 2018 Feb 13, 2019	BUY	$22.73 - $42.34 $4.06 Million - $7.57 Million	178,821 Added 30.0%	774,873 $22.1 Million
Q3 2018 Nov 13, 2018	BUY	$44.35 - $65.71 $9.49 Million - $14.1 Million	213,988 Added 56.01%	596,052 $26.4 Million
Q2 2018 Aug 14, 2018	SELL	$42.62 - $73.59 $2.77 Million - $4.78 Million	-64,984 Reduced 14.54%	382,064 $22.5 Million
Q1 2018 May 15, 2018	BUY	$23.52 - $58.17 $98,854 - $244,488	4,203 Added 0.95%	447,048 $20.4 Million
Q4 2017 Feb 14, 2018	BUY	$16.95 - $23.48 $6.15 Million - $8.52 Million	362,797 Added 453.22%	442,845 $10.4 Million
Q3 2017 Nov 14, 2017	BUY	$16.75 - $20.66 $804 - $991	48 Added 0.06%	80,048 $1.43 Million
Q2 2017 Aug 14, 2017	BUY	N/A	80,000	80,000 $1.28 Million

Others Institutions Holding CRSP

# of Institutions

490

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.18B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account